BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38465576)

  • 1. A recurrent missense variant in the E3 ubiquitin ligase substrate recognition subunit FEM1B causes a rare syndromic neurodevelopmental disorder.
    Lecoquierre F; Punt AM; Ebstein F; Wallaard I; Verhagen R; Studencka-Turski M; Duffourd Y; Moutton S; Tran Mau-Them F; Philippe C; Dean J; Tennant S; Brooks AS; van Slegtenhorst MA; Jurgens JA; Barry BJ; Chan WM; England EM; Martinez Ojeda M; Engle EC; Robson CD; Morrow M; Innes AM; Lamont R; Sanderson M; Krüger E; Thauvin C; Distel B; Faivre L; Elgersma Y; Vitobello A
    Genet Med; 2024 Mar; 26(6):101119. PubMed ID: 38465576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights into SMCR8 C-degron recognition by FEM1B.
    Zhao S; Ru W; Chen X; Liao S; Zhu Z; Zhang J; Xu C
    Biochem Biophys Res Commun; 2021 Jun; 557():236-239. PubMed ID: 33892462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fem1b promotes ubiquitylation and suppresses transcriptional activity of Gli1.
    Gilder AS; Chen YB; Jackson RJ; Jiang J; Maher JF
    Biochem Biophys Res Commun; 2013 Oct; 440(3):431-6. PubMed ID: 24076122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo missense variants in the E3 ubiquitin ligase adaptor KLHL20 cause a developmental disorder with intellectual disability, epilepsy, and autism spectrum disorder.
    Sleyp Y; Valenzuela I; Accogli A; Ballon K; Ben-Zeev B; Berkovic SF; Broly M; Callaerts P; Caylor RC; Charles P; Chatron N; Cohen L; Coppola A; Cordeiro D; Cuccurullo C; Cuscó I; Janette diMonda ; Duran-Romaña R; Ekhilevitch N; Fernández-Alvarez P; Gordon CT; Isidor B; Keren B; Lesca G; Maljaars J; Mercimek-Andrews S; Morrow MM; Muir AM; ; Rousseau F; Salpietro V; Scheffer IE; Schnur RE; Schymkowitz J; Souche E; Steyaert J; Stolerman ES; Vengoechea J; Ville D; Washington C; Weiss K; Zaid R; Sadleir LG; Mefford HC; Peeters H
    Genet Med; 2022 Dec; 24(12):2464-2474. PubMed ID: 36214804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insights into the ubiquitylation strategy of the oligomeric CRL2
    Dai Z; Liang L; Wang W; Zuo P; Yu S; Liu Y; Zhao X; Lu Y; Jin Y; Zhang F; Ding D; Deng W; Yin Y
    EMBO J; 2024 Mar; 43(6):1089-1109. PubMed ID: 38360992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FEM1 proteins are ancient regulators of SLBP degradation.
    Dankert JF; Pagan JK; Starostina NG; Kipreos ET; Pagano M
    Cell Cycle; 2017 Mar; 16(6):556-564. PubMed ID: 28118078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications.
    Henning NJ; Manford AG; Spradlin JN; Brittain SM; Zhang E; McKenna JM; Tallarico JA; Schirle M; Rape M; Nomura DK
    J Am Chem Soc; 2022 Jan; 144(2):701-708. PubMed ID: 34994556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure and regulation of Cullin 2 based E3 ubiquitin ligases and their biological functions.
    Cai W; Yang H
    Cell Div; 2016; 11():7. PubMed ID: 27222660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis and regulation of the reductive stress response.
    Manford AG; Mena EL; Shih KY; Gee CL; McMinimy R; Martínez-González B; Sherriff R; Lew B; Zoltek M; Rodríguez-Pérez F; Woldesenbet M; Kuriyan J; Rape M
    Cell; 2021 Oct; 184(21):5375-5390.e16. PubMed ID: 34562363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel de novo FEM1C variant is linked to neurodevelopmental disorder with absent speech, pyramidal signs and limb ataxia.
    Dubey AA; Krygier M; Szulc NA; Rutkowska K; Kosińska J; Pollak A; Rydzanicz M; Kmieć T; Mazurkiewicz-Bełdzińska M; Pokrzywa W; Płoski R
    Hum Mol Genet; 2023 Mar; 32(7):1152-1161. PubMed ID: 36336956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cellular Mechanism to Detect and Alleviate Reductive Stress.
    Manford AG; Rodríguez-Pérez F; Shih KY; Shi Z; Berdan CA; Choe M; Titov DV; Nomura DK; Rape M
    Cell; 2020 Oct; 183(1):46-61.e21. PubMed ID: 32941802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De Novo Variants in the F-Box Protein FBXO11 in 20 Individuals with a Variable Neurodevelopmental Disorder.
    Gregor A; Sadleir LG; Asadollahi R; Azzarello-Burri S; Battaglia A; Ousager LB; Boonsawat P; Bruel AL; Buchert R; Calpena E; Cogné B; Dallapiccola B; Distelmaier F; Elmslie F; Faivre L; Haack TB; Harrison V; Henderson A; Hunt D; Isidor B; Joset P; Kumada S; Lachmeijer AMA; Lees M; Lynch SA; Martinez F; Matsumoto N; McDougall C; Mefford HC; Miyake N; Myers CT; Moutton S; Nesbitt A; Novelli A; Orellana C; Rauch A; Rosello M; Saida K; Santani AB; Sarkar A; Scheffer IE; Shinawi M; Steindl K; Symonds JD; Zackai EH; ; ; Reis A; Sticht H; Zweier C
    Am J Hum Genet; 2018 Aug; 103(2):305-316. PubMed ID: 30057029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo variants in
    Buratti J; Ji L; Keren B; Lee Y; Booke S; Erdin S; Kim SY; Palculict TB; Meiner V; Chae JH; Woods CG; Tam A; Héron D; Cong F; Harel T
    J Med Genet; 2021 Mar; 58(3):205-212. PubMed ID: 32430360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome.
    Goodarzi MO; Maher JF; Cui J; Guo X; Taylor KD; Azziz R
    Hum Reprod; 2008 Dec; 23(12):2842-9. PubMed ID: 18757445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse Fem1b interacts with and induces ubiquitin-mediated degradation of Ankrd37.
    Shi YQ; Liao SY; Zhuang XJ; Han CS
    Gene; 2011 Oct; 485(2):153-9. PubMed ID: 21723927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human FEM1B is required for Rad9 recruitment and CHK1 activation in response to replication stress.
    Sun TP; Shieh SY
    Oncogene; 2009 May; 28(18):1971-81. PubMed ID: 19330022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atlas on substrate recognition subunits of CRL2 E3 ligases.
    Wang S; Xia W; Qiu M; Wang X; Jiang F; Yin R; Xu L
    Oncotarget; 2016 Jul; 7(29):46707-46716. PubMed ID: 27107416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent
    Tan NB; Pagnamenta AT; Ferla MP; Gadian J; Chung BH; Chan MC; Fung JL; Cook E; Guter S; Boschann F; Heinen A; Schallner J; Mignot C; Keren B; Whalen S; Sarret C; Mittag D; Demmer L; Stapleton R; Saida K; Matsumoto N; Miyake N; Sheffer R; Mor-Shaked H; Barnett CP; Byrne AB; Scott HS; Kraus A; Cappuccio G; Brunetti-Pierri N; Iorio R; Di Dato F; Pais LS; Yeung A; Tan TY; Taylor JC; Christodoulou J; White SM
    J Med Genet; 2022 May; 59(5):511-516. PubMed ID: 34183358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RACK1 downregulates levels of the pro-apoptotic protein Fem1b in apoptosis-resistant colon cancer cells.
    Subauste MC; Ventura-Holman T; Du L; Subauste JS; Chan SL; Yu VC; Maher JF
    Cancer Biol Ther; 2009 Dec; 8(23):2297-305. PubMed ID: 19855191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant recurrence in neurodevelopmental disorders: the use of publicly available genomic data identifies clinically relevant pathogenic missense variants.
    Lecoquierre F; Duffourd Y; Vitobello A; Bruel AL; Urteaga B; Coubes C; Garret P; Nambot S; Chevarin M; Jouan T; Moutton S; ; Tran-Mau-Them F; Philippe C; Sorlin A; Faivre L; Thauvin-Robinet C
    Genet Med; 2019 Nov; 21(11):2504-2511. PubMed ID: 31036916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.